Jamaica Plain, MA, United States of America

Roberto A Maldonado

USPTO Granted Patents = 19 

 

 

Average Co-Inventor Count = 1.9

ph-index = 9

Forward Citations = 371(Granted Patents)


Location History:

  • Berkeley, CA (US) (2022)
  • Jamaica Plain, MA (US) (2014 - 2023)

Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: Exploring the Innovations of Roberto A. Maldonado in Allergy Therapy

Introduction: Roberto A. Maldonado, a prominent inventor based in Jamaica Plain, MA, has made significant contributions to the field of allergy therapy. With a remarkable portfolio of 19 patents, his work primarily focuses on developing innovative therapeutic solutions to improve the lives of those suffering from allergies.

Latest Patents: Two of Maldonado's latest patents demonstrate his cutting-edge approach to allergy therapy. The first, titled "Tolerogenic Synthetic Nanocarriers for Allergy Therapy," discloses synthetic nanocarrier compositions and related methods that incorporate immunosuppressants and MHC Class II-restricted epitopes of an allergen. These innovations provide tolerogenic immune responses specific to the allergen, offering a new frontier in allergy treatment. The second patent, "Tolerogenic Synthetic Nanocarriers," relates to compositions featuring synthetic nanocarriers and immunosuppressants that foster immune suppressive effects. These compositions can also include antigens, leading to antigen-specific tolerogenic immune responses that may revolutionize existing allergy treatments.

Career Highlights: Roberto A. Maldonado is currently associated with Selecta Biosciences, Inc., a company dedicated to advancing the field of immunotherapy and improving patient care. His expertise in developing novel therapeutic approaches has garnered recognition within scientific communities and has the potential to transform allergy treatment.

Collaborations: Throughout his career, Maldonado has collaborated with esteemed colleagues, including Christopher C. Fraser and Takashi Kei Kishimoto. These partnerships have facilitated the exchange of ideas and innovation, contributing to the development of cutting-edge solutions in allergy therapy.

Conclusion: Roberto A. Maldonado's contributions to the field of allergy therapy through his patents and collaborations underscore the importance of innovation in healthcare. His work not only enhances our understanding of allergic responses but also paves the way for more effective treatments, thereby improving the quality of life for individuals with allergies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…